2009
DOI: 10.5483/bmbrep.2009.42.5.286
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of LPS-induced nitric oxide production by transduced Tat-arginine deiminase fusion protein in Raw 264.7 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Protein transduction technology based on small domains called protein transduction domains (PTDs) and cell penetrating peptides (CPPs) has been used to deliver exogenous protein into cultured cells and animal models (2)(3)(4)(5)(6)(7). Many research groups have demonstrated the efficacy of protein transduction technology for protein therapy strategies as well as drug delivery, although the exact mechanism of transduction remains unclear (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Although various proteins have been developed for protein therapy, protein transduction technology has several limitations such as transduction efficiency.…”
Section: Introductionmentioning
confidence: 99%
“…Protein transduction technology based on small domains called protein transduction domains (PTDs) and cell penetrating peptides (CPPs) has been used to deliver exogenous protein into cultured cells and animal models (2)(3)(4)(5)(6)(7). Many research groups have demonstrated the efficacy of protein transduction technology for protein therapy strategies as well as drug delivery, although the exact mechanism of transduction remains unclear (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Although various proteins have been developed for protein therapy, protein transduction technology has several limitations such as transduction efficiency.…”
Section: Introductionmentioning
confidence: 99%